,address1,address2,city,country,phone,website,longBusinessSummary,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,"82, 2sandan-ro",Ochang-eup Cheongwon-gu,Cheongju,South Korea,82 4 3717 7000,https://www.celltrionph.com,"Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.","{'maxAge': 1, 'name': 'Sang-Suk  Kim', 'title': 'Pres', 'exercisedValue': 0, 'unexercisedValue': 0}",1,9,7,10,9,1693526400,86400,2,70500.0,69800.0,69400.0,70600.0,70500.0,69800.0,69400.0,70600.0,0.349695,134797,134797,495841,137179,137179,70100.0,70200.0,0,0,2390485630976,56200.0,101200.0,8.7012,78116.0,75770.664,KRW,2826010099712,0.09473,17596918,34052500,0.55004,0.059510004,1609372800,1640908800,1617148800,2.284,26025797632,1:1,1514332800,10.286,66.034,KOE,EQUITY,068760.KQ,068760.KQ,Celltrionph,"Celltrion Pharm, Inc.",1138924800,Asia/Seoul,KST,32400000,70200.0,none,34627596288,878.377,42796433408,191750144000,0.923,1.235,274730598400,63.335,6962.839,0.03407,0.08912,72933397450,-20097181696,28435218432,2.262,0.927,0.29426,0.15578,0.10514,KRW,
1,"82, 2sandan-ro",Ochang-eup Cheongwon-gu,Cheongju,South Korea,82 4 3717 7000,https://www.celltrionph.com,"Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.","{'maxAge': 1, 'name': 'Jung-su  Seo', 'title': 'CEO & Internal Director', 'exercisedValue': 0, 'unexercisedValue': 0}",1,9,7,10,9,1693526400,86400,2,70500.0,69800.0,69400.0,70600.0,70500.0,69800.0,69400.0,70600.0,0.349695,134797,134797,495841,137179,137179,70100.0,70200.0,0,0,2390485630976,56200.0,101200.0,8.7012,78116.0,75770.664,KRW,2826010099712,0.09473,17596918,34052500,0.55004,0.059510004,1609372800,1640908800,1617148800,2.284,26025797632,1:1,1514332800,10.286,66.034,KOE,EQUITY,068760.KQ,068760.KQ,Celltrionph,"Celltrion Pharm, Inc.",1138924800,Asia/Seoul,KST,32400000,70200.0,none,34627596288,878.377,42796433408,191750144000,0.923,1.235,274730598400,63.335,6962.839,0.03407,0.08912,72933397450,-20097181696,28435218432,2.262,0.927,0.29426,0.15578,0.10514,KRW,
